See more : Jourdeness Group Limited (4190.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Biomotion Sciences Warrant (SLXNW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biomotion Sciences Warrant, a leading company in the Biotechnology industry within the Healthcare sector.
- United Health Products, Inc. (UEEC) Income Statement Analysis – Financial Results
- Extra Space Storage Inc. (EXR) Income Statement Analysis – Financial Results
- Integra LifeSciences Holdings Corporation (IART) Income Statement Analysis – Financial Results
- Experience Co Limited (EXP.AX) Income Statement Analysis – Financial Results
- VIA Holdings,Inc. (7918.T) Income Statement Analysis – Financial Results
Biomotion Sciences Warrant (SLXNW)
About Biomotion Sciences Warrant
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Source: https://incomestatements.info
Category: Stock Reports